TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis

Abstract

The pathological effects of multiple sclerosis are not confined to lesions; tissues that appear normal on conventional magnetic resonance imaging scans are also affected, albeit subtly. One imaging technique that has proven sensitive to such effects is T1-relaxation time measurement, with previous work demonstrating abnormalities in normal-appearing white matter and grey matter. In this work we investigated the evolution of T1-relaxation time changes in normal-appearing white matter and grey matter in relapsing—remitting multiple sclerosis. Three- and five-year follow-up data from 35 people with clinically early (a mean of 1.6 years from first clinical event) relapsing—remitting multiple sclerosis and 15 healthy controls were analysed. T1-relaxation time histograms were extracted from normal-appearing white matter and grey matter, and mean, peak height and peak location values were estimated. T1-relaxation time peak height declined in the multiple sclerosis normal-appearing white matter and grey matter, but not the control group (rate difference p = 0.024 in normal-appearing white matter, in normal-appearing grey matter p = 0.038); other T1-relaxation time changes were not significantly different between groups. Changes in T1-relaxation time measures did not correlate with increases in brain T2-weighted lesion loads or Expanded Disability Status Scale scores. These results suggest that the processes underlying changes in normal-appearing white matter and grey matter T1-relaxation times are not immediately linked to white matter lesion formation, and may represent more diffuse but progressive sub-clinical pathology in relapsing—remitting multiple sclerosis.

Keywords

Multiple sclerosis relapsing—remitting MRI T1-relaxation times longitudinal

Get full access to this article

View all access options for this article.

References

Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002; 15: 239-245.

Fisniku LK , Brex PA , Altmann DR , et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008; 131: 808-817.

Tintore M. , Rovira A. , Rio J. , et al. Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 2006; 67: 968-972.

Beck RW , Smith CH , Gal RL , et al. Neurologic impairment 10 years after optic neuritis. Arch Neurol 2004; 61: 1386-1389.

Minneboo A. , Barkhof F. , Polman CH , Uitdehaag BM , Knol DL , Castelijns JA Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 2004; 61: 217-221.

Filippi M. , Rocca MA MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 2005; 252(suppl 5): v16-24. Review.

Ceccarelli A. , Rocca MA , Falini A. , et al. Normal-appearing white and grey matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla. J Neurol 2007; 254: 513-518.

Vrenken H. , Geurts JJ , Knol DL , et al. Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology 2006; 240: 811-820.

Vrenken H. , Rombouts SA , Pouwels PJ , Barkhof F. Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter. AJNR Am J Neuroradiol 2006; 27: 868-874.

10.

Davies GR , Ramio-Torrentà L. , Hadjiprocopis A. , et al. Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2004; 75: 998-1002.

11.

Parry A. , Clare S. , Jenkinson M. , Smith S. , Palace J. , Matthews PM MRI brain T1 relaxation time changes in MS patients increase over time in both the white matter and the cortex. J Neuroimaging 2003; 13: 234-239.

12.

Cercignani M. , Bozzali M. , Iannucci G. , Comi G. , Filippi M. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis . J Neurol Neurosurg Psychiatry 2001; 70: 311-317.

13.

Rovaris M. , Judica E. , Ceccarelli A. , et al. A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS. J Neurol 2008; 255: 1209-1214.

14.

Davies GR , Hadjiprocopis A. , Altmann DR , et al. Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study. Mult Scler 2007; 13: 169-177.

15.

Agosta F. , Rovaris M. , Pagani E. , Sormani MP , Comi G. , Filippi M. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006; 129: 2620-2627.

16.

Davies GR , Altmann DR , Hadjiprocopis A. , et al. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing- remitting multiple sclerosis . J Neurol 2005; 252: 1037-1044.

17.

Griffin CM , Dehmeshki J. , Chard DT , et al. T1 histograms of normal-appearing brain tissue are abnormal in early relapsing-remitting multiple sclerosis. Mult Scler 2002; 8: 211-216.

18.

Lublin FD , Reingold SC Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911.

19.

Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.

20.

Lechner-Scott J. , Kappos L. , Hofman M. , et al. Can the Expanded Disability Status Scale be assessed by telephone? Mult Scler 2003; 9: 154-159.

21.

Parker GJ , Barker GJ , Tofts PS Accurate multislice gradient echo T(1) measurement in the presence of non-ideal RF pulse shape and RF field nonuniformity. Magn Reson Med 2001; 45: 838-845.

22.

Woods RP , Grafton ST , Holmes CJ , Cherry SR , Mazziotta JC Automated Image Registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 1998; 22: 139-152.

23.

Grimaud J. , Lai M. , Thorpe J. , et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 1996; 14: 499-505.

24.

Ashburner J. , Friston KJ Voxel-based morphometry - the methods. Neuroimage 2000; 11: 805-821.

25.

Kutzelnigg A. , Faber-Rod JC , Bauer J. , et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007; 17: 38-44.

26.

Barnes D. , McDonald WI , Johnson G. , Tofts PS , Landon DN Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. J Neurol Neurosurg Psychiatry 1987; 50: 125-133.

27.

Naruse S. , Horikawa Y. , Tanaka C. , Hirakawa K. , Nishikawa H. , Yoshizaki K. Proton nuclear magnetic resonance studies on brain edema. J Neurosurg 1982; 56: 747-752.

28.

Schmierer K. , Scaravilli F. , Altmann DR , Barker GJ , Miller DH Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004; 56: 407-415.

29.

Schmierer K. , Tozer DJ , Scaravilli F. , et al. Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J Magn Reson Imaging 2007 ; 26: 41-51.

30.

Geurts JJ , Pouwels PJ , Uitdehaag BM , Polman CH , Barkhof F. , Castelijns JA Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005; 236: 254-260.

31.

Manfredonia F. , Ciccarelli O. , Khaleeli Z. , et al. Normal-appearing brain T1 relaxation time predicts disability in early primary progressive multiple sclerosis. Arch Neurol 2007; 64: 411-415.

32.

Chapman C. , Tubridy N. , Cook MJ , et al. Short-term effects of methylprednisolone on cerebral volume in multiple sclerosis relapses. J Clin Neurosci 2006; 13: 636-638.

33.

Saito N. , Sakai O. , Ozonoff A. , Jara H. Relaxo-volumetric multispectral quantitative magnetic resonance imaging of the brain over the human lifespan: global and regional aging patterns. Magn Reson Imaging 2009; 27: 895-906.